This gene is involved in epigenetic modification of DNA.
Persistence of DNMT3A mutations at long-term remission in adult patients with AML.
The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.